rs1060503769
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PVS1_StrongPM2PP3PP5_Very_Strong
The NM_003002.4(SDHD):c.315G>A(p.Trp105*) variant causes a stop gained, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003002.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHD | NM_003002.4 | c.315G>A | p.Trp105* | stop_gained, splice_region_variant | Exon 4 of 4 | ENST00000375549.8 | NP_002993.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHD | ENST00000375549.8 | c.315G>A | p.Trp105* | stop_gained, splice_region_variant | Exon 4 of 4 | 1 | NM_003002.4 | ENSP00000364699.3 | ||
ENSG00000255292 | ENST00000532699.1 | n.314+5794G>A | intron_variant | Intron 3 of 5 | 3 | ENSP00000456434.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pheochromocytoma;C1847319:Carney-Stratakis syndrome;C1868633:Paragangliomas with sensorineural hearing loss;CN166604:Cowden syndrome 3 Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the last exon of the SDHD mRNA at codon 105 (p.Trp105*). While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated SDHD protein. For these reasons, this variant has been classified as Pathogenic. This particular variant has not been reported in the literature, but a different variant (c.314G>A) with the same protein effect (p.Trp105*) has been reported in an individual affected with pheochromocytomas (PCC) and paragangliomas (PGL) (PMID: 23512077). While no functional studies have been performed to test the effects of this particular variant on SDHD protein function or stability, it deletes 55 C-terminal amino acid residues from the SDHD protein. A founder mutation (p.Leu139Pro) has been reported in this region (PMID: 21348866, 11391798), and a downstream truncating variant has been classified as likely pathogenic in the Invitae database, indicating that the C-terminal amino acid residues may be critical for SDHD function. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W105* pathogenic mutation (also known as c.315G>A), located in coding exon 4 of the SDHD gene, results from a G to A substitution at nucleotide position 315. This changes the amino acid from a tryptophan to a stop codon within coding exon 4. An adjacent nucleotide change, c.314G>A, which results in the same stop codon, was reported in multiple patients diagnosed with paragangliomas (Fishbein L et al. Ann Surg Oncol. 2013 May;20(5):1444-50). Based on the available evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at